Grant: Discovery Grants Program - Individual
University of Toronto
$32,000.00
A novel phosphoinositide signaling pathway in hematopoiesis and stem cell maintenance
FY 2018-19
Summary
All cells that make up human blood derive from a tiny population of hematopoietic stem cells (HSCs). To support the blood system throughout a lifetime HSCs have specialized protective strategies in place to maintain their capacity for self-renewal and survival. For instance, HSCs exist in a slow cycling state to minimize stresses associated with replication, and they reside within bone marrow cavities to be protected from excessive cellular respiration and the damaging effects of oxidative stress. Increasing evidence supports an essential role for autophagy to maintain healthy HSCs. Autophagy is a cellular recycling system which can eliminate damaged organelles and other potentially threatening cellular components. Inactivation of autophagy leads to loss of HSCs and the collapse of hematopoiesis and is characterized by accumulation of dysfunctional mitochondria, DNA damage and aberrant cell death and proliferation. Our research aims to characterize the mechanisms by which autophagy is regulated and how it protects HSCs. Phosphoinositide signalling has been demonstrated to influence both HSC homeostasis and autophagy independently; however how these phenomena may be linked is not clear. Our recent studies have identified novel unexpected functions of the phosphoinositide regulating protein called inositol polyphosphate-4-phosphatase type II (INPP4B) in blood cells. We have identified that high levels of INPP4B is a characteristic that identifies HSCs. Moreover, we have demonstrated that INPP4B overexpression confers elevated levels of cellular autophagy. Given these data, we hypothesize that the elevated expression levels of INPP4B in primordial blood cells contributes to stem cell maintenance by facilitating the activation of autophagic protective mechanisms. This hypothesis will be explored by investigating the physiological role of INPP4B in HSC function in knockout and transgenic mouse models; by developing new cellular and animal models to characterize INPP4B-mediated autophagy; and investigating the role of sits role of INPP4B-mediated autophagy on HSC function in vivo. Understanding how autophagy is controlled and how it protects HSCs can have wide-reaching implications for the development of stem cell-based technologies, artificial blood manufacturing and medicine.*
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-03984
Name nom
Salmena, Leonardo
Department département
Pharmacology and Toxicology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2015
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
4
Nb partie
5
Application title
A novel phosphoinositide signaling pathway in hematopoiesis and stem cell maintenance
Keyword
NSERC
Application summary
All cells that make up human blood derive from a tiny population of hematopoietic stem cells (HSCs). To support the blood system throughout a lifetime HSCs have specialized protective strategies in place to maintain their capacity for self-renewal and survival. For instance, HSCs exist in a slow cycling state to minimize stresses associated with replication, and they reside within bone marrow cavities to be protected from excessive cellular respiration and the damaging effects of oxidative stress. Increasing evidence supports an essential role for autophagy to maintain healthy HSCs. Autophagy is a cellular recycling system which can eliminate damaged organelles and other potentially threatening cellular components. Inactivation of autophagy leads to loss of HSCs and the collapse of hematopoiesis and is characterized by accumulation of dysfunctional mitochondria, DNA damage and aberrant cell death and proliferation. Our research aims to characterize the mechanisms by which autophagy is regulated and how it protects HSCs. Phosphoinositide signalling has been demonstrated to influence both HSC homeostasis and autophagy independently; however how these phenomena may be linked is not clear. Our recent studies have identified novel unexpected functions of the phosphoinositide regulating protein called inositol polyphosphate-4-phosphatase type II (INPP4B) in blood cells. We have identified that high levels of INPP4B is a characteristic that identifies HSCs. Moreover, we have demonstrated that INPP4B overexpression confers elevated levels of cellular autophagy. Given these data, we hypothesize that the elevated expression levels of INPP4B in primordial blood cells contributes to stem cell maintenance by facilitating the activation of autophagic protective mechanisms. This hypothesis will be explored by investigating the physiological role of INPP4B in HSC function in knockout and transgenic mouse models; by developing new cellular and animal models to characterize INPP4B-mediated autophagy; and investigating the role of sits role of INPP4B-mediated autophagy on HSC function in vivo. Understanding how autophagy is controlled and how it protects HSCs can have wide-reaching implications for the development of stem cell-based technologies, artificial blood manufacturing and medicine.*